Literature DB >> 19524408

A prospective longitudinal volumetric MRI study of superior temporal gyrus gray matter and amygdala-hippocampal complex in chronic schizophrenia.

Takeshi Yoshida1, Robert W McCarley, Motoaki Nakamura, KangUk Lee, Min-Seong Koo, Sylvain Bouix, Dean F Salisbury, Lindsay Morra, Martha E Shenton, Margaret A Niznikiewicz.   

Abstract

A progressive post-onset decrease in gray matter volume 1.5 years after first hospitalization in schizophrenia has been shown in superior temporal gyrus (STG). However, it is still controversial whether progressive volume reduction occurs in chronic schizophrenia in the STG and amygdala-hippocampal complex (AHC), structures found to be abnormal in chronic schizophrenia. These structures were measured at two time points in 16 chronic schizophrenia patients and 20 normal comparison subjects using manual tracing with high spatial resolution magnetic resonance imaging (MRI). Average interscan interval was 3.1 years for schizophrenia patients and 1.4 years for healthy comparison subjects. Cross-sectional comparisons showed smaller relative volumes in schizophrenia compared with controls in posterior STG and AHC. An ANCOVA with interscan interval as a covariate showed there was no statistically significant progression of volume reduction in either the STG or AHC in the schizophrenia group compared with normal subjects. In the schizophrenia group, volume change in the left anterior AHC significantly correlated with PANSS negative symptoms. These data, and separately reported first episode data from our laboratory, suggest marked progression at the initial stage of schizophrenia, but less in chronic schizophrenia.

Entities:  

Mesh:

Year:  2009        PMID: 19524408      PMCID: PMC2776716          DOI: 10.1016/j.schres.2009.05.004

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  66 in total

1.  Focal gray matter changes in schizophrenia across the course of the illness: a 5-year follow-up study.

Authors:  Neeltje E M van Haren; Hilleke E Hulshoff Pol; Hugo G Schnack; Wiepke Cahn; René C W Mandl; D Louis Collins; Alan C Evans; René S Kahn
Journal:  Neuropsychopharmacology       Date:  2007-02-28       Impact factor: 7.853

Review 2.  Structure and function of declarative and nondeclarative memory systems.

Authors:  L R Squire; S M Zola
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-26       Impact factor: 11.205

3.  Ten year progressive ventricular enlargement in schizophrenia: an MRI morphometrical study.

Authors:  T Saijo; T Abe; Y Someya; T Sassa; Y Sudo; T Suhara; T Shuno; K Asai; Y Okubo
Journal:  Psychiatry Clin Neurosci       Date:  2001-02       Impact factor: 5.188

4.  Auditory hallucinations and smaller superior temporal gyral volume in schizophrenia.

Authors:  P E Barta; G D Pearlson; R E Powers; S S Richards; L E Tune
Journal:  Am J Psychiatry       Date:  1990-11       Impact factor: 18.112

5.  Hippocampus and amygdala in schizophrenia: assessment of the relationship of neuroanatomy to psychopathology.

Authors:  R Rajarethinam; J R DeQuardo; J Miedler; S Arndt; R Kirbat; J A Brunberg; R Tandon
Journal:  Psychiatry Res       Date:  2001-11-30       Impact factor: 3.222

6.  Effect of ketamine on the neuromagnetic mismatch field in healthy humans.

Authors:  I Kreitschmann-Andermahr; T Rosburg; U Demme; E Gaser; H Nowak; H Sauer
Journal:  Brain Res Cogn Brain Res       Date:  2001-08

7.  Progressive brain volume changes and the clinical course of schizophrenia in men: a longitudinal magnetic resonance imaging study.

Authors:  D H Mathalon; E V Sullivan; K O Lim; A Pfefferbaum
Journal:  Arch Gen Psychiatry       Date:  2001-02

8.  Progressive and interrelated functional and structural evidence of post-onset brain reduction in schizophrenia.

Authors:  Dean F Salisbury; Noriomi Kuroki; Kiyoto Kasai; Martha E Shenton; Robert W McCarley
Journal:  Arch Gen Psychiatry       Date:  2007-05

9.  Glutamate and glutamine in the anterior cingulate and thalamus of medicated patients with chronic schizophrenia and healthy comparison subjects measured with 4.0-T proton MRS.

Authors:  Jean Théberge; Yousef Al-Semaan; Peter C Williamson; Ravi S Menon; Richard W J Neufeld; Nagalingam Rajakumar; Betsy Schaefer; Maria Densmore; Dick J Drost
Journal:  Am J Psychiatry       Date:  2003-12       Impact factor: 18.112

10.  Cortical activity associated with auditory hallucinations.

Authors:  Axel Ropohl; Wolfgang Sperling; Samuel Elstner; Bernd Tomandl; Udo Reulbach; Martin Kaltenhäuser; Johannes Kornhuber; Christian Maihöfner
Journal:  Neuroreport       Date:  2004-03-01       Impact factor: 1.837

View more
  25 in total

1.  Re: Progressive volume reduction and its relation to the different stages of schizophrenia.

Authors:  Takeshi Yoshida; Robert W McCarley; Margaret A Niznikiewicz
Journal:  Schizophr Res       Date:  2010-06-15       Impact factor: 4.939

2.  Gray matter volume alterations in first-episode drug-naïve patients with deficit and nondeficit schizophrenia.

Authors:  Wei Lei; Wei Deng; Mingli Li; Zongling He; Yuanyuan Han; Chaohua Huang; Xiaohong Ma; Qiang Wang; Wanjun Guo; Yinfei Li; Lijun Jiang; Qiyong Gong; Xun Hu; Nanyin Zhang; Tao Li
Journal:  Psychiatry Res       Date:  2015-09-11       Impact factor: 3.222

Review 3.  Dendritic spine pathology in neuropsychiatric disorders.

Authors:  Peter Penzes; Michael E Cahill; Kelly A Jones; Jon-Eric VanLeeuwen; Kevin M Woolfrey
Journal:  Nat Neurosci       Date:  2011-03       Impact factor: 24.884

4.  Progressive alterations of the auditory association areas in young non-psychotic offspring of schizophrenia patients.

Authors:  Tejas S Bhojraj; John A Sweeney; Konasale M Prasad; Shaun Eack; Rajaprabhakaran Rajarethinam; Alan N Francis; Debra M Montrose; Matcheri S Keshavan
Journal:  J Psychiatr Res       Date:  2010-06-11       Impact factor: 4.791

5.  CACNA1C genotype explains interindividual differences in amygdala volume among patients with schizophrenia.

Authors:  Claudia Wolf; Holger Mohr; Thomas Schneider-Axmann; Andreas Reif; Thomas Wobrock; Harald Scherk; Susanne Kraft; Andrea Schmitt; Peter Falkai; Oliver Gruber
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2013-07-24       Impact factor: 5.270

6.  Overlapping and distinct gray and white matter abnormalities in schizophrenia and bipolar I disorder.

Authors:  Dana Anderson; Babak A Ardekani; Katherine E Burdick; Delbert G Robinson; Majnu John; Anil K Malhotra; Philip R Szeszko
Journal:  Bipolar Disord       Date:  2013-06-25       Impact factor: 6.744

7.  Aging effects on regional brain structural changes in schizophrenia.

Authors:  Igor Nenadić; Heinrich Sauer; Stefan Smesny; Christian Gaser
Journal:  Schizophr Bull       Date:  2011-02-04       Impact factor: 9.306

Review 8.  Dendritic spine pathology in schizophrenia.

Authors:  J R Glausier; D A Lewis
Journal:  Neuroscience       Date:  2012-04-27       Impact factor: 3.590

Review 9.  Is early intervention for psychosis feasible and effective?

Authors:  Vinod H Srihari; Jai Shah; Matcheri S Keshavan
Journal:  Psychiatr Clin North Am       Date:  2012-07-21

10.  Amygdala volume is reduced in early course schizophrenia.

Authors:  Alyson M Rich; Youngsun T Cho; Yanqing Tang; Aleksandar Savic; John H Krystal; Fei Wang; Ke Xu; Alan Anticevic
Journal:  Psychiatry Res Neuroimaging       Date:  2016-02-12       Impact factor: 2.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.